Natural products are considered to be good sources for the screening of lead compounds of clinical drugs. We performed a large number of drug screenings by using a variety of assay systems with crude extracts of microbial cultures as a traditional natural product library. In some assay systems, our crude extract library could not work effectively. With this in mind, we started to construct a purified natural compound library possessing various skeletons from cultures of microorganisms. As actinomycetes are known to produce pharmaceutically useful compounds, 1,2 we focused mainly on secondary metabolites from cultures of actinomycetes. To achieve this, we established a high-throughput system for the detection of secondary metabolites from the cultures of actinomycetes with the retentiontime and HR-MS data of known compounds by using a UPLC-TOF-MS system (Waters, Milford, MA, USA). 3 We analyzed the secondary metabolites, including potential novel compounds, present in the cultures of the strains isolated from a variety of resources by this system. 3 In the course of our chemical screening program, a new furaquinocin derivative named JBIR-136 (1, Figure 1a) , together with the known compound kujimycin A, 4 was isolated from a culture broth of Streptomyces sp. 4963H2. This paper describes the fermentation, isolation, structural elucidation and, in brief, the biological activity of 1.
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Streptomyces sp. 4963H2 was isolated from a soil sample collected in Kimitsu, Chiba Prefecture, Japan. The strain was cultivated in 50-ml test tubes, each containing 15 ml of a seed medium consisting of 1.0% starch (Kosokagaku, Tokyo, Japan), 1.0% polypeptone (Nihon Pharmaceutical, Tokyo, Japan), 1.0% molasses (Dai-Nippon Meiji Sugar, Tokyo, Japan) and 1.0% meat extract (Extract Ehlrich, Wako Pure Chemical Industry, Osaka, Japan) at pH 7.2 (adjusted before sterilization). The test tubes were shaken on a reciprocal shaker (320 r.p.m.) at 27 1C for 2 days. Aliquots (2.5 ml) of the broth were transferred to 500-ml baffled Erlenmeyer flasks containing 100 ml of a production medium consisting of 2.0% glycerol (Nacalai Tesque, Kyoto, Japan), 1.0% molasses (Dai-Nippon Meiji Sugar), 0.5% casein (Kanto Chemical, Tokyo, Japan), 0.1% polypeptone (Nihon Pharmaceutical) and 0.4% CaCO 3 (Kozaki Pharmaceutical, Tokyo, Japan) at pH 7.2 (adjusted before sterilization), and were cultured on a rotary shaker (180 r.p.m.) at 27 1C for 5 days.
The fermentation broth (2 l) was separated by centrifugation. The supernatant was partitioned between EtOAc and H 2 O (2lÂ 3), whereas the mycelial cake was extracted with acetone (50 ml) and filtered, and the filtrate was concentrated in vacuo. The residual aqueous concentrate was extracted with EtOAc (equal volume Â 3). The combined EtOAc layers were dried over Na 2 SO 4 , and then evaporated to dryness. The residue (733 mg) was subjected to normalphase medium pressure liquid chromatography (Purif-Pack SI-30, Shoko Scientific, Yokohama, Japan) and developed successively with a gradient system of n-hexane-EtOAc (0-15% EtOAc) followed by the stepwise solvent system of CHCl 3 -MeOH (0, 2, 5, 10, 20, 30 and 100% MeOH). The 5% MeOH-eluted fraction (91.3 mg) was then subjected to preparative reversed-phase HPLC on a CAPCELL PAK C18 MGII column (5.0 mm, 20 i.d. Â 150 mm; Shiseido, Tokyo, Japan) with 60% aqueous MeOH containing 0.1% formic acid (flow rate: 10 ml min À1 ) to give 1 (7.2 mg; retention time: 10.6 min).
Compound 1 was a pale yellow amorphous solid ([a] 24 D -38, c 0.36 in MeOH; UV l max (e) in MeOH: 233 (17 000), 281 (12 000) and 316 (5600) nm). The IR spectrum (n max (attenuated total reflectance) 3380 and 1652 cm À1 ) indicated the presence of hydroxy and carbonyl groups. The molecular formula was determined as C 21 H 28 O 6 by highresolution ESI MS (m/z 375.1790 [M-H] -, calcd for C 21 H 27 O 6 375.1808). The direct connectivity between protons and carbons was established by a heteronuclear single quantum coherence spectrum; the tabulated 13 C and 1 H NMR spectroscopic data for 1 are listed in Table 1 . A planar structure was elucidated through the analysis of the DQF-COSY and constant-time (CT-HMBC) 5 data, as described below.
The sequence from the oxymethine proton 6-H (d respectively. In addition, the HMBC coupling from the oxymethine proton 2-H to the aromatic carbon C-9b established that these carbons were connected through an ether bond. The index of hydrogen deficiency of eight allowed the final determination of the structure of 1, as shown in Figure 1a . The relative configuration of 1 was determined from NOESY and the J values. From the 1 H NMR spectrum, large coupling constants of 3 J 6-H,7-H ¼ 7.2 Hz and 3 J 7-H,8-Hb ¼ 7.8 Hz and a small coupling value of 3 J 7-H,8-Ha ¼ 3.6 Hz were obtained. The NOESY spectrum showed a correlation between 6-H and 8-Hb. On the basis of these data, 6-H, 7-H and 8-Hb are found to be in pseudoaxial positions, whereas 8-Ha and O-7 are in pseudoequatorial positions, as shown in Figure 1c . The NOESY correlation of 2-H/17-H implied that CH 3 -16 and CH 3 -17 were in the trans orientation. For the C-3/C-10 axis, NOESY correlations from 11-H 2 to 16-H and 17-H showed gauche orientation between C-11 and C-17. Furthermore, a strong NOESY correlation between 10-H and 16-H was seen, whereas no correlation was observed for 10-H/17-H, indicating gauche orientation between C-17 and the oxygen atom O-10. On the other hand, 1 H-13 C coupling constants of 3 J 10H-C17 ¼ 4.8 Hz, 3 J 10H-C2 o2.8 Hz and 3 J 10H-C3a o2.8 Hz were obtained from the analysis of the J-resolved HMBC-2 spectrum. 6 According to the J-based configuration analysis method, 7 this result strongly supported the relative configuration described above. Taken together, the relative configurations at C-2, C-3 and C-10 were elucidated to be R*, S* and R*, respectively, as shown in Figure 1d .
The absolute configuration of 1 was determined using a modified Mosher's method 8 From these values, it was found that C-6 and C-10 were arranged in the R configuration. Given this result, the absolute configurations of 1 were assigned as 2R, 3S, 6R, 7R and 10R.
The structure of 1 is related to those of the furaquinocins, 9-13 in particular furaquinocin D, 11, 12 isolated as the secondary metabolite of Streptomyces. As furaquinocins show cytotoxicity against cancer cells, we evaluated the cytotoxic activity of 1 against human cervical carcinoma HeLa cells by using a (2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium monosodium salt (WST-8) colorimetric assay (Cell Counting Kit; Dojindo, Kumamoto, Japan) for 72 h. The results showed that 1 exhibited a weak cytotoxicity, with an IC 50 value of 44.4 mM.
